US SB1315 | 2009-2010 | 111th Congress
Status
Spectrum: Partisan Bill (Democrat 2-0)
Status: Introduced on June 22 2009 - 25% progression, died in chamber
Action: 2009-06-22 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on June 22 2009 - 25% progression, died in chamber
Action: 2009-06-22 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Text: Latest bill text (Introduced) [PDF]
Summary
Drug Price Competition Act of 2009 - Amends the Federal Food, Drug, and Cosmetic Act to expand the definition of "first applicant" under such Act to allow a generic drug manufacturer that is currently considered an applicant subsequent to a brand-name manufacturer's 180-day exclusivity period to qualify as a first applicant for purposes of filing an abbreviated application for a new drug. Requires such applicant to submit a substantially complete application that contains and lawfully maintains a certification for such drug.
Title
Drug Price Competition Act of 2009
Sponsors
| Sen. Herb Kohl [D-WI] | Sen. Bill Nelson [D-FL] |
History
| Date | Chamber | Action |
|---|---|---|
| 2009-06-22 | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Same As/Similar To
HB3777 (Same As) 2009-10-09 - Referred to the Subcommittee on Health.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/111th-congress/senate-bill/1315/all-info |
| Text | https://www.congress.gov/111/bills/s1315/BILLS-111s1315is.pdf |
